Past, present and future of xanthine oxidase inhibitors: design strategies, structural and pharmacological insights, patents and clinical trials-Reference-Cited by-同舟云学术

Past, present and future of xanthine oxidase inhibitors: design strategies, structural and pharmacological insights, patents and clinical trials

Published:2023 Issue:11 Volume:14 Page:2155-2191
ISSN:2632-8682
Container-title:RSC Medicinal Chemistry
language:en
Short-container-title:RSC Med. Chem.

Author:

Singh Atamjit¹^ORCID,Singh Karanvir¹,Sharma Aman¹,Kaur Kirandeep¹,Chadha Renu²^ORCID,Singh Bedi Preet Mohinder¹³

Affiliation:

1. Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab 143005, India

2. University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160014, India

3. Drug and Pollution Testing Laboratory, Guru Nanak Dev University, Amritsar, Punjab 143005, India

Abstract

Xanthine oxidase, a molybdo-flavoenzyme, and an isoform of xanthine dehydrogenase both exist as xanthine oxidoreductase and are responsible for purine catabolism.

Funder

University Grants Commission

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/MD/D3MD00316G

Reference172 articles.

1. R.Bray , 6 Molybdenum iron-sulfur flauin hydroxylases and related enzymes, in The enzymes , Elsevier , 1975 , vol. 12 , pp. 299–419

2. Note on the Vitamine Content of Milk

3. Studies on Xanthine Oxidase

4. Xanthine oxidase and xanthine dehydrogenase

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of aurones and chalcones as the main contributors to xanthine oxidase inhibitory activity of snow chrysanthemum;Food Bioscience;2024-10

2. Emerging Roles of Xanthine Oxidoreductase in Chronic Kidney Disease;Antioxidants;2024-06-12

3. Characterization, In Silico Antimalarial, Antiinflammatory, Antioxidant, and ADMET Assessment of Neonauclea excelsa Merr.;Sciences of Pharmacy;2024-05-08

4. Heterocyclic compounds as xanthine oxidase inhibitors for the management of hyperuricemia: synthetic strategies, structure–activity relationship and molecular docking studies (2018–2024);RSC Medicinal Chemistry;2024

5. Potential New Drug Targets Modulating the Environmentally-Induced Oxidative Stress in the Cardiovascular System;Advances in Biochemistry in Health and Disease;2024